Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis

JAMA. 2023 Feb 28;329(8):684-685. doi: 10.1001/jama.2022.22870.

Authors

Chi-Kuei Hsu¹, Wen-Wen Tsai², Chih-Cheng Lai³

Affiliations

¹ Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan.
² Department of Education, Chi Mei Medical Center, Tainan, Taiwan.
³ Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.

PMID: 36853255
DOI: 10.1001/jama.2022.22870

No abstract available

Publication types

Comparative Study
Letter
Comment

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Cefepime* / therapeutic use
Drug Therapy, Combination
Humans
Piperacillin* / adverse effects
Pyelonephritis* / complications
Pyelonephritis* / drug therapy
Tazobactam* / therapeutic use
Urinary Tract Infections* / complications
Urinary Tract Infections* / drug therapy

Substances

Cefepime
enmetazobactam
Piperacillin
Tazobactam
Anti-Bacterial Agents